XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.54−0.08 (-4.94%)
Close on Nov 18, 2026Market cap $14.57MP/E –Yield –
XTL Biopharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2024 it was $3.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.00K | – |
See a number that looks wrong?